ProFem GmbH
🇦🇹Austria
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- ProFem GmbH
- Target Recruit Count
- 432
- Registration Number
- NCT04734405
- Locations
- 🇦🇹
Universitätsklinik für Gynäkologie und Geburthilfe, Uni-Klinik IBK, Innsbruck, Tirol, Austria
🇵🇱Centrum Zdrowia Kobiety Komed,, Kielce, Poland
🇦🇹Ambulatorium für Pilzinfektionen und andere infektiöse venero-dermatologische Erkrankungen, Wien, Austria
ProF-001_Phase IIa
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- ProFem GmbH
- Target Recruit Count
- 84
- Registration Number
- NCT03115073
- Locations
- 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
🇦🇹Bezirkskrankenhaus Schwaz, Schwaz, Austria
🇦🇹Medical University Vienna, Vienna, Austria
© Copyright 2024. All Rights Reserved by MedPath